225 related articles for article (PubMed ID: 2523411)
1. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.
Gewirtz AM; Calabretta B; Rucinski B; Niewiarowski S; Xu WY
J Clin Invest; 1989 May; 83(5):1477-86. PubMed ID: 2523411
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro.
Han ZC; Sensébe L; Abgrall JF; Brière J
Blood; 1990 Mar; 75(6):1234-9. PubMed ID: 2310823
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura.
Han ZC; Bellucci S; Tenza D; Caen JP
Br J Haematol; 1990 Apr; 74(4):395-401. PubMed ID: 2140694
[TBL] [Abstract][Full Text] [Related]
4. Chemokine regulation of human megakaryocytopoiesis.
Gewirtz AM; Zhang J; Ratajczak J; Ratajczak M; Park KS; Li C; Yan Z; Poncz M
Blood; 1995 Oct; 86(7):2559-67. PubMed ID: 7670101
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III).
Han ZC; Bellucci S; Walz A; Baggiolini M; Caen JP
Int J Cell Cloning; 1990 Jul; 8(4):253-9. PubMed ID: 2401804
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of highly purified human platelet beta-thromboglobulin on in vitro human megakaryocyte colony formation.
Abgrall JF; Han ZC; Sensebe L; Le Gall G; Guern G; Renard I; Briere J
Exp Hematol; 1991 Mar; 19(3):202-5. PubMed ID: 1825299
[TBL] [Abstract][Full Text] [Related]
7. Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin.
Lebeurier I; Basara N; Aïdoudi S; Amiral J; Caen JP; Han ZC
Br J Haematol; 1996 Jan; 92(1):29-34. PubMed ID: 8562407
[TBL] [Abstract][Full Text] [Related]
8. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC
Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183
[TBL] [Abstract][Full Text] [Related]
9. Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines.
Lebeurier I; Raclet L; Amiral J; Caen JP; Han ZC
J Lab Clin Med; 1996 Feb; 127(2):179-85. PubMed ID: 8636646
[TBL] [Abstract][Full Text] [Related]
10. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents.
Han ZC; Lu M; Li J; Defard M; Boval B; Schlegel N; Caen JP
Blood; 1997 Apr; 89(7):2328-35. PubMed ID: 9116276
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
13. Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: comparative studies with transforming growth factor beta1.
Xi X; Caen JP; Fournier S; Schlegel N; Amiral J; Sibony O; Blot P; Han ZC
Br J Haematol; 1996 May; 93(2):265-72. PubMed ID: 8639415
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of thrombopoietic-stimulatory factor and spleen cell-conditioned medium on megakaryocytopoiesis in a short-term bone marrow liquid culture system.
Petursson SR; Chervenick PA
Exp Hematol; 1988 Sep; 16(8):660-6. PubMed ID: 3261250
[TBL] [Abstract][Full Text] [Related]
15. Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.
Lambert MP; Rauova L; Bailey M; Sola-Visner MC; Kowalska MA; Poncz M
Blood; 2007 Aug; 110(4):1153-60. PubMed ID: 17495129
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.
Han ZC; Maurer AM; Bellucci S; Wan HY; Kroviarski Y; Bertrand O; Caen JP
J Lab Clin Med; 1992 Oct; 120(4):645-60. PubMed ID: 1402341
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human megakaryocytopoiesis.
Han ZC; Bellucci S; Caen JP
Nouv Rev Fr Hematol (1978); 1990; 32(6):395-6. PubMed ID: 2101871
[TBL] [Abstract][Full Text] [Related]
18. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.
Straneva JE; Briddell RA; McDonald TP; Yang HH; Hoffman R
Exp Hematol; 1989 Dec; 17(11):1122-7. PubMed ID: 2684680
[TBL] [Abstract][Full Text] [Related]
19. New insights into the regulation of human megakaryocytopoiesis.
Hoffman R; Straneva J; Yang HH; Bruno E; Brandt J
Blood Cells; 1987; 13(1-2):75-86. PubMed ID: 3499196
[TBL] [Abstract][Full Text] [Related]
20. [Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].
Han ZC; Zhang XJ; Xi XD; Lu M; Jiang S; Jiang LZ; Wang XM; Gu GL; Caen JP
Shi Yan Sheng Wu Xue Bao; 1995 Dec; 28(4):415-26. PubMed ID: 8731973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
